title: Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.
abstract: We studied the cause of death in a consecutive series of 164 patients with Wilson's disease (WD) diagnosed over an 11 year period. A total of 20 [12% (95% CI 10.3-16.0)] died during the observation period. The relative survival rate of all patients in our group was statistically smaller than in Polish population. The main cause of death was the diagnosis in advanced stage of disease, but in six patients presenting with mild signs, we observed the progression of the disease despite treatment. There was no difference in mortality rate in patients treated with d-penicillamine or zinc sulphate as initial therapy. The prognosis for survival in the majority of WD patients is favourable, provided that therapy is introduced early.
authors.affiliation: czlonkow@ipin.edu.pl
authors.forename: A
authors.initials: A
authors.lastname: Członkowska
authors.forename: B
authors.initials: B
authors.lastname: Tarnacka
authors.forename: T
authors.initials: T
authors.lastname: Litwin
authors.forename: J
authors.initials: J
authors.lastname: Gajda
authors.forename: M
authors.initials: M
authors.lastname: Rodo
mesh_terms: D000328:Adult; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016001:Confidence Intervals; D003300:Copper / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality*; D006801:Humans; D008297:Male; D019370:Observation / Q000379:methods*; D010396:Penicillamine / Q000627:therapeutic use; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D019287:Zinc Sulfate / Q000627:therapeutic use
chemical_list: D019287:Zinc Sulfate; D003300:Copper; D010396:Penicillamine
references.citation: Mov Disord. 1988;3(1):10-29
references.pmid: 3050468
references.citation: J Gastroenterol Hepatol. 1990 Jul-Aug;5(4):420-4
references.pmid: 2129813
references.citation: Am J Med. 1956 Oct;21(4):487-95
references.pmid: 13362281
references.citation: J Lab Clin Med. 1992 Sep;120(3):380-6
references.pmid: 1517684
references.citation: J Neurol. 1996 Mar;243(3):269-73
references.pmid: 8936358
references.citation: Arch Neurol. 1991 Jan;48(1):42-7
references.pmid: 1986725
references.citation: Gastroenterology. 1991 Mar;100(3):762-7
references.pmid: 1993498
references.citation: Nat Genet. 1995 Feb;9(2):210-7
references.pmid: 7626145
references.citation: Lancet. 1982 Mar 20;1(8273):643-7
references.pmid: 6121964
references.citation: Eur J Clin Pharmacol. 1977 Dec 2;12(4):265-71
references.pmid: 590312
references.citation: Arch Neurol. 1987 May;44(5):490-3
references.pmid: 3579660
references.citation: Gut. 1983 Aug;24(8):767-71
references.pmid: 6307837
references.citation: Acta Univ Carol Med Monogr. 1973;56:175-7
references.pmid: 4791768
references.citation: J Clin Gastroenterol. 1989 Apr;11(2):220-4
references.pmid: 2472436
references.citation: Comput Programs Biomed. 1985;19(2-3):197-207
references.pmid: 3839736
references.citation: J Neurol Sci. 1976 Oct;29(2-4):411-21
references.pmid: 978218
references.citation: Brain. 2000 Mar;123 Pt 3:585-90
references.pmid: 10686180
references.citation: J Hepatol. 1988 Dec;7(3):305-9
references.pmid: 2853189
references.citation: Arch Neurol. 2000 Feb;57(2):276-7
references.pmid: 10681092
references.citation: N Engl J Med. 1987 Jul 23;317(4):209-13
references.pmid: 3600712